Telehealth ADHD Prescribing: What Psychiatrists Can Do in Georgia

You spent years training to help patients with ADHD — but now you’re navigating a maze of telehealth rules, state-by-state restrictions, and shifting DEA policies. If you’ve searched ‘Can psychiatrists prescribe ADHD medication via telehealth?’ or ‘What are the prescribing limits for PMHNPs treating ADHD?’, you’re not alone.

The short answer: Yes, psychiatrists can prescribe ADHD medication, including Schedule II stimulants like Adderall and Ritalin, via telehealth — for now. But the reality is more nuanced, especially as federal flexibilities wind down and state laws vary dramatically.

Whether you’re an MD considering telehealth or a PMHNP trying to understand your scope, this guide cuts through the regulatory fog and shows you what’s actually happening on the ground in 2026.

What Psychiatrists Need to Know About ADHD Prescribing Authority

Full Prescriptive Authority — No Asterisks

As a psychiatrist (MD or DO), you have unrestricted authority to prescribe any ADHD medication in every state. No supervision required. No quantity limits. No special permission needed beyond your:

• Valid state medical license
• DEA registration (Schedule II-V)
• State controlled substance registration (where required)

This puts you in a unique position. While nurse practitioners face a patchwork of restrictions — some states won’t let them prescribe stimulants at all — you can manage ADHD medication completely independently.

The Telehealth Reality: Still Legal, But Temporary

Here’s where it gets complicated. Under the Ryan Haight Act, prescribing Schedule II controlled substances via telemedicine normally requires at least one in-person exam. During COVID, the DEA waived that requirement entirely.

Current status (through December 31, 2025): The DEA and HHS extended the pandemic-era telehealth flexibilities for a third time, allowing you to initiate stimulant prescriptions for new ADHD patients entirely via video visit (www.axios.com).

The catch: This is temporary. Without further action from Congress or the DEA, the in-person requirement could snap back in 2026. The agencies have kicked the can down the road repeatedly (www.axios.com), but nothing is permanent yet.

What this means for your practice: Plan for contingencies. If you’re building a telehealth ADHD practice, have a backup plan for in-person exams (partnerships with local clinics, hybrid models) in case the rules change. But for now, you’re cleared to prescribe stimulants via video.

State-Specific Telehealth Rules to Watch

While federal law sets the baseline, some states add their own layers:

Florida explicitly permits telehealth prescribing of stimulants for psychiatric disorders — ADHD qualifies (www.flsenate.gov). Florida carved out this exception because they wanted to allow mental health care while restricting pain management prescribing.

Texas allows telehealth prescribing of controlled substances for mental health conditions, but only via live video (no phone-only) and not for chronic pain management (www.cchpca.org). ADHD treatment is fine; just make sure your platform uses video.

Most other states (California, New York, Pennsylvania, Illinois) don’t impose additional telehealth barriers beyond federal law. You’re following the same DEA rules everyone else is.

One universal requirement: check your state’s Prescription Drug Monitoring Program (PDMP). New York mandates checking the PMP before every controlled substance prescription. Other states require it at least quarterly for ongoing patients. Build this into your workflow — it’s non-negotiable.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

ADHD Prescribing: What Works via Telehealth (And What Doesn’t)

Clinical Workflow for Telehealth ADHD Care

ADHD diagnosis is fundamentally history-based, which translates well to telemedicine. Here’s what you can do effectively via video:

Initial Evaluation (45-60 minutes):

• Comprehensive psychiatric interview using DSM-5 criteria
• Standardized rating scales (ASRS for adults, Vanderbilt for children) sent electronically
• Collateral information (teacher reports, partner observations, previous records)
• Mental status exam focusing on attention, impulse control, executive function
• Screen for comorbidities (anxiety, depression, substance use)

Medication Initiation:

• e-Prescribe stimulants through DEA-compliant platforms (two-factor authentication required)
• Most telehealth platforms integrate with Surescripts or similar systems
• Start with standard doses based on age, weight, and symptom severity
• Document thoroughly: presenting symptoms, diagnosis rationale, treatment plan, informed consent covering stimulant risks

Follow-Up Visits (typically monthly, 10-15 minutes):

• Symptom monitoring using brief scales or structured interviews
• Side effect assessment (appetite, sleep, blood pressure, heart rate)
• Adherence check
• PDMP review (quarterly minimum, more often if concerns)
• Dose adjustments as needed
• Refill prescriptions (30-day supplies standard for Schedule II)

What You’ll Need Patients to Do:

• Self-report vital signs (ask them to get a home BP cuff or use a pharmacy machine)
• For patients with cardiac history or risk factors, coordinate with their PCP for baseline EKG if appropriate (not universally required, but good practice for older patients)
• Periodic urine drug screens if you have concerns about diversion or co-occurring substance use (some practices mail test kits; others refer to local labs)

The Stuff You Can’t Do Remotely (But Rarely Need To)

Unlike some specialties, ADHD medication management has minimal hands-on requirements. You’re not doing:

• Physical exams (beyond what patients can self-report)
• Procedures or injections (all ADHD meds are oral)
• Complex assessments requiring in-person presence

The only real limitation is if you want continuous vital sign monitoring during titration — which almost no one does in outpatient ADHD care anyway.

Addressing the Elephant in the Room: Quality and Compliance

The telehealth ADHD space got a black eye in 2023-2024 when some companies (notably Cerebral and Done) faced scrutiny for over-prescribing stimulants with minimal oversight — brief messaging-based ‘evaluations,’ no follow-up, treating patients the company’s own clinicians flagged as inappropriate (capitol.texas.gov).

You’re not that. But regulators are watching, so document defensively:

• Use synchronous video (not just chat or phone) for diagnosis and initial prescribing
• Conduct evaluations that would satisfy an in-person standard of care
• Schedule regular follow-ups (monthly is standard for stimulant management)
• Verify patient identity and location each visit
• Don’t prescribe stimulants as a first-line treatment without confirming the diagnosis
• Have clear policies for red flags (requests for early refills, lost prescriptions, out-of-state pharmacy requests)

If your practice can stand up to a state medical board audit, you’re fine. If you’re rubber-stamping Adderall requests in five-minute chats, you’re in dangerous territory.

PMHNP vs Psychiatrist: What’s the Difference for ADHD Prescribing?

This is where things get messy. Your scope as a psychiatrist is the same everywhere. A PMHNP’s scope? It depends entirely on where they’re licensed.

The Spectrum of NP Authority

Full Practice Authority (FPA) States:In states like New York (after 3,600 supervised hours), Illinois (after 4,000 hours + extra training), and California (transitioning to independence for experienced NPs), PMHNPs can eventually prescribe ADHD medications independently — no MD oversight required (rxagent.co).

These NPs have DEA registrations, check the PDMP just like you do, and manage their own caseloads. They’re essentially functioning as you would, just with a nursing license instead of a medical degree.

Restricted States (Where Psychiatrists Are Essential):

Texas is the most restrictive. NPs must have physician supervision for all practice, but here’s the kicker: Texas law prohibits NPs from prescribing Schedule II stimulants outside hospital or hospice settings (rxagent.co).

Translation: A PMHNP in Texas cannot write an outpatient Adderall prescription. Period. They need a psychiatrist to do it.

This is why psychiatrists are in such high demand in Texas telehealth. You’re not competing with NPs — you’re the only option for stimulant prescribing in routine ADHD care.

Florida requires NPs to work under a psychiatrist’s protocol. The general rule limits NPs to 7-day supplies of Schedule II drugs, but there’s an exception: psychiatric nurses treating mental health disorders can prescribe beyond 7 days (www.leg.state.fl.us).

So a Florida PMHNP can prescribe a 30-day supply of Adderall, but only if they’re credentialed as a psychiatric nurse and working under a psychiatrist’s supervision.

Pennsylvania allows NPs to prescribe stimulants, but with a weird constraint: initial prescriptions are limited to 72 hours, and the NP must notify their collaborating physician. Ongoing prescriptions can be 30-day supplies (rxagent.co).

This creates workflow friction. Many practices have the psychiatrist write the initial script to avoid the 72-hour headache, then the NP handles monthly refills.

What This Means for Team-Based Care

If you’re practicing in a restricted state, you’re not just treating your own patients — you’re the linchpin enabling NPs to provide care. In a telehealth setting, this might mean:

• Collaborative agreements where you oversee 4-7 NPs (depending on state caps)
• Chart reviews (some states mandate periodic review of NP cases)
• Being available for consults on complex cases
• Writing initial stimulant prescriptions in states like Pennsylvania

You’re compensated for this oversight in some models (salary or per-patient fees), but it’s also extra liability and responsibility. Know your state’s rules on how many NPs you can supervise and what ‘supervision’ actually requires.

In FPA states, NPs are your colleagues, not subordinates. You might work in the same telehealth practice but manage separate patient panels.

The Economics: What You’ll Actually Get Paid

Let’s talk money. Because all the regulatory clarity in the world doesn’t matter if you can’t make a living.

Insurance Reimbursement for Telehealth Psychiatry

The good news: telehealth payment parity is nearly universal in 2026 (behavehealth.com). Almost every state requires or strongly encourages insurers to pay the same rate for video visits as in-person.

Medicare rates (2024-2025 fee schedule):

• CPT 99213 (15-minute medication management visit): ~$89-95
• CPT 99214 (25-minute visit): ~$125-136
• CPT 90792 (initial psychiatric evaluation with medical services): ~$188-202

(therathink.com)

Commercial insurance typically pays 100-130% of Medicare rates — sometimes more in high-cost-of-living areas like NYC or San Francisco.

Medicaid pays less (often 40-60% of Medicare), which translates to roughly $40-65 for a med check in many states (therathink.com). If you’re Medicaid-heavy, you’ll need higher volume to hit income targets.

Quick Math on a Telehealth ADHD Practice

Let’s say you’re doing medication management visits (mostly 15-minute follow-ups after initial evals):

• 4 patients/hour at $100/visit average = $400/hour gross
• 20 clinical hours/week = $8,000/week gross = ~$416,000/year before overhead

Overhead in telehealth is much lower than brick-and-mortar (no office rent, smaller staff, centralized billing). Figure 20-30% overhead vs 40-50% for traditional practices.

Net income potential: $280,000-$330,000 working part-time hours, which is competitive with or better than many outpatient psychiatry roles.

The bottleneck isn’t reimbursement — it’s patient volume and scheduling efficiency. Telehealth solves a lot of that (no commutes for patients = fewer no-shows, easier to fill cancellations).

Why Psychiatrists Get Paid More Than NPs (And Why It Matters)

Psychiatrists bill at 100% of the fee schedule. NPs bill at roughly 85% under their own NPI with many payers (therathink.com).

This isn’t just a pay differential — it’s a reflection of how the system values full physician training and responsibility. For telehealth platforms, recruiting psychiatrists can mean higher revenue per visit, which is why many platforms actively compete for MDs.

You have leverage. Use it when negotiating contracts.

State-by-State Breakdown: Where ADHD Prescribers Are Needed Most

Texas: Huge Demand, Restrictive Rules

The shortage: Texas ranks 43rd nationally with roughly 1 psychiatrist per 9,000 residents (www.healingpsychiatryflorida.com). Over 185 of 254 counties are designated shortage areas.

The opportunity: High demand for ADHD services, especially in rural areas and mid-sized cities. Many patients waiting months for appointments.

The catch: NPs can’t prescribe stimulants for outpatient ADHD, so psychiatrists are the only option for medication management. This creates huge demand for MDs, but also means you’ll carry a heavier caseload if you’re the sole prescriber.

Telehealth specifics: Must use live video (not phone-only) for controlled substance prescribing. Statewide licensure allows you to serve patients across all 254 counties.

Reimbursement: Texas doesn’t mandate payment parity by law, but most major insurers (BCBS TX, United, Aetna) pay telehealth at in-person rates. Medicaid pays lower but has expanded telehealth coverage.

Florida: Growing Market, Collaborative Model

The shortage: Ranks 42nd with about 1 psychiatrist per 8,577 residents (www.healingpsychiatryflorida.com). Miami has decent coverage, but North Florida and interior regions are deserts.

The opportunity: Large, growing population (22+ million). High prevalence of ADHD diagnosis. State law explicitly allows telehealth prescribing of stimulants for psychiatric conditions.

The collaborative angle: Florida PMHNPs can prescribe ADHD meds if working under a psychiatrist’s protocol. You could build a team-based model: you oversee 4 NPs (state max), handle complex cases and initial prescriptions, NPs manage stable patients.

Reimbursement: Coverage parity enforced. Florida’s insurance rates are moderate (not as high as Northeast, not as low as some Southern states).

California: Competitive but Enormous

The supply: About 1 psychiatrist per 5,000 residents — near the national average. Concentrated in LA, SF, San Diego metro areas (www.healingpsychiatryflorida.com).

The gap: Rural Central Valley, Inland Empire, far Northern California are all shortage areas despite the state’s overall numbers.

NP landscape: California is transitioning to NP independence. Experienced NPs (3+ years) can now practice without physician oversight. This increases competition from PMHNPs, but also means you’re less likely to get pulled into supervisory roles unless you want them.

Tech-savvy patients: California has a huge population that’s comfortable with telehealth. Adult ADHD awareness is high, especially in tech industry hubs where productivity concerns drive diagnosis.

Reimbursement: Among the best in the nation. Commercial insurers pay well due to high cost of living. Covered California plans include robust mental health benefits.

New York: Best Provider Supply, Still Gaps Upstate

The supply: Ranks 4th nationally with 1 psychiatrist per ~2,900 residents — heavily concentrated in NYC metro (www.healingpsychiatryflorida.com).

The gap: Upstate NY (Adirondacks, parts of Western NY) and rural areas have severe shortages despite the state’s overall numbers.

NP independence: After 3,600 supervised hours, PMHNPs can practice fully independently, including prescribing stimulants. Many experienced NPs in NYC and surrounding areas.

Telehealth advantage: A NYC-based psychiatrist can serve patients in Buffalo, Syracuse, or rural counties via telemedicine, filling gaps without relocating.

Compliance note: New York requires checking the PDMP (I-STOP registry) before every controlled substance prescription. Build this into your workflow or risk fines.

Reimbursement: Excellent in NYC metro (high commercial rates). Medicaid rates are low but volume is available if you take it.

Pennsylvania: Moderate Supply, Workflow Quirks

The supply: About 1 psychiatrist per 4,586 residents — slightly better than average, but rural central and northern PA have shortages (www.healingpsychiatryflorida.com).

NP restrictions: PMHNPs need collaborative agreements and can only prescribe 72-hour initial supplies of Schedule II drugs. This creates friction; many practices have the psychiatrist handle initial scripts.

Team model: If you’re supervising NPs, expect to be more hands-on initially. After the first prescription, NPs can write 30-day refills.

Reimbursement: Solid coverage and parity. Medicaid made permanent telehealth coverage including mental health.

Illinois: Moving Toward NP Independence

The supply: About 1 psychiatrist per 5,849 residents — moderate. Chicago metro has good coverage; downstate and rural areas have gaps (www.healingpsychiatryflorida.com).

NP landscape: After 4,000 supervised hours, NPs can obtain Full Practice Authority and prescribe independently. Many experienced PMHNPs are now independent.

Telehealth friendly: Strong parity laws, Medicaid coverage for telehealth. Requires patient consent for telehealth (document it each visit).

Reimbursement: Good coverage. Chicago commercial rates are solid; downstate rates lower but still viable.

Making the Economics Work: DIY Marketing vs Platform Models

Here’s the reality most providers don’t talk about: acquiring ADHD patients isn’t cheap or easy.

The Hidden Costs of DIY Patient Acquisition

Let’s break down what it actually costs to get a psychiatric patient through your own marketing:

SEO (Search Engine Optimization):

• Timeline: 6-12 months before you see meaningful patient flow
• Cost: $2,000-5,000/month for an SEO agency, or hundreds of hours of your own time learning and implementing
• Reality: By month 6, you might get 10-15 quality leads/month if you’re lucky. Most providers don’t have the patience or expertise.

Google Ads:

• Keywords like ‘ADHD psychiatrist near me’ or ‘online ADHD evaluation’ cost $15-40+ per click
• Conversion rates: Generous estimate is 5-10% of clicks become booked patients
• Math: 100 clicks at $25/click = $2,500 spent. If 7 book appointments, that’s $357 per booked patient. And that assumes they all show up and become ongoing patients.

Psychology Today & Directory Listings:

• Monthly fees: $30-100+ per directory
• You’re competing with hundreds of other providers on the same page
• Zero control over which patients see you or when
• Quality varies wildly (many tire-kickers, insurance shoppers, folks who ghost after initial inquiry)

Reality Check: When you factor in all costs — agency fees, ad spend, failed campaigns, no-shows from cold leads, staff time to handle and qualify leads — most solo providers spend $200-500+ to acquire each established psychiatric patient through DIY marketing.

And that’s after months of investment with no guarantee of results.

The Platform Model: Pay Only for Patients You See

This is where a service like Klarity Health changes the math entirely.

How it works:

• Klarity handles all marketing, patient acquisition, and qualification
• Patients come to the platform specifically looking for ADHD evaluation/treatment
• You pay a standard listing fee per new patient lead (similar to how Zocdoc works)
• No upfront costs. No monthly subscription. No wasted ad spend on clicks that don’t convert.

What you get:

• Pre-qualified patients already matched to your specialty, availability, and insurance acceptance
• Built-in telehealth infrastructure (no separate platform costs)
• Both insurance and cash-pay patient flow depending on your preferences
• Full schedule control — you decide when you’re available, which patients to see, how many to take on
• Guaranteed ROI — you only pay when a qualified patient actually books with you

The economic comparison:

DIY Marketing:

• $3,000-5,000/month burn rate
• 6-12 months before results
• Uncertainty about patient quality and volume
• Requires expertise you probably don’t have (and don’t want to learn)
• Ongoing time commitment managing campaigns

Klarity Platform:

• $0 monthly spend
• Patients available immediately upon credentialing
• Pre-qualified and matched to your practice
• Zero time spent on marketing
• Predictable, scalable patient acquisition

For most providers, especially those starting out or scaling up, the platform model removes all the risk and lets you focus on what you actually trained to do: treating patients.

The Hybrid Approach

Some established providers use both: they maintain their own SEO and referral networks (which can eventually generate patients at lower marginal cost) while also using platforms to fill schedule gaps or rapidly scale up.

There’s no one-size-fits-all answer. But if you’re reading this and thinking ‘I just want to treat ADHD patients without becoming a marketing expert,’ a platform is your fastest path to a full schedule and sustainable income.

The Patient Shortage Reality (Hint: There Isn’t One)

Here’s the secret: there’s no shortage of ADHD patients. There’s a shortage of providers.

Demand surge context:

• ADHD prescriptions surged 10-20% during COVID as telehealth made care more accessible (apnews.com)
• Adult ADHD awareness has exploded (partially driven by social media, partially by reduced stigma)
• Many patients have been waiting months or even years to get evaluated by a psychiatrist
• Pediatric ADHD wait times in some markets exceed 6-12 months

What this means for you:

• Building a full caseload is not a problem — managing demand is
• You can be selective about patients (focus on your preferred age groups, complexity levels, insurance vs cash)
• Pricing power for cash-pay models (many markets will sustain $200-400+ per initial eval, $100-150 for follow-ups)
• Job security and flexibility — if you don’t like your current arrangement, there are 10 other opportunities

The bottleneck isn’t patients. It’s your time and the regulatory hoops to practice across state lines.

What’s Coming: Regulatory Changes to Watch

Federal Telehealth Prescribing (The Big Unknown)

The December 31, 2025 deadline is approaching fast. Three scenarios:

1. Congress passes permanent telehealth legislation codifying controlled substance prescribing via telemedicine (most likely outcome given bipartisan support, but Congress is unpredictable)

2. DEA finalizes a ‘special registration’ rule for telemedicine providers who meet certain criteria (proposed but not implemented) (rxagent.co)

3. The waiver expires and we revert to the Ryan Haight Act requiring in-person exams (worst case, but providers would likely get a grace period to adjust)

What to do now:

• Stay connected to professional organizations (APA, AACAP) for updates
• Have contingency plans (partner clinics for in-person exams, hybrid models)
• Don’t build your entire practice on the assumption current flexibilities are permanent

State NP Scope Laws (Slowly Expanding)

Several states have pending legislation to expand NP independence:

• Pennsylvania has repeatedly proposed FPA bills (not passed yet, but momentum building)
• Texas has floated limited NP independence (unlikely to pass given political climate)
• More states considering adopting the APRN Compact (would allow cross-state NP practice)

For psychiatrists: expanded NP scope doesn’t hurt you — in most cases it reduces your supervisory burden while still leaving you as the expert for complex cases.

ADHD Medication Shortages (Ongoing Concern)

The shortage reality:Stimulant shortages have been intermittent since late 2022 due to DEA manufacturing quotas and supply chain issues (www.axios.com). The DEA has increased production limits, but tight supply persists.

What this means clinically:

• Be prepared to prescribe alternative stimulants (if Adderall is backordered, try Vyvanse, methylphenidate, or generics)
• Know which pharmacies in your patients’ areas have better stock
• Have non-stimulant options ready (atomoxetine, bupropion, clonidine/guanfacine)
• Set expectations with patients that finding their medication might take a few calls

The upside: This shortage has actually increased demand for psychiatrists, because patients can’t get medications from their PCPs (who often don’t have time to navigate the shortage) and need specialist expertise to switch meds safely.

FAQ: ADHD Prescribing for Psychiatrists

Can psychiatrists prescribe Adderall via telehealth in 2026?

Yes, through at least December 31, 2025, under extended DEA flexibilities. Beyond that, unclear — federal policy is in flux. State laws (like Florida’s explicit allowance for psychiatric telehealth prescribing) may provide additional protection in some states.

Do I need a DEA registration to prescribe ADHD medications via telehealth?

Yes. You need your standard DEA registration for the state where you’re licensed. Some proposed (but not implemented) rules discussed a separate ‘telemedicine DEA registration,’ but as of 2026 that doesn’t exist — use your regular DEA number.

What’s the difference between a psychiatrist and a PMHNP for ADHD treatment?

Clinically, both can diagnose and manage ADHD. Legally, psychiatrists have full independent authority in all states, while PMHNPs face varying restrictions (from full independence in states like New York to near-total prohibition in states like Texas). If you’re an MD, you have maximum flexibility and fewer hoops to jump through.

Can I prescribe across state lines via telehealth?

Only if you’re licensed in the state where the patient is physically located during the visit. Interstate compacts (IMLC for physicians) make it easier to get multiple state licenses, but you still need a license in each state you practice in. No ‘national’ telemedicine license exists.

How do I check the PDMP for telehealth patients?

Each state has its own Prescription Monitoring Program database. Most integrate with e-prescribing platforms or have web portals. You’ll need to register for access in each state where you’re licensed. Some states (like New York) require checking before every controlled substance prescription; others require it at least quarterly.

What if my patient’s pharmacy doesn’t have their ADHD medication in stock?

Have backup options ready. Keep a list of pharmacies in different chains that might have better stock. Be prepared to write scripts for alternative stimulants. Consider non-stimulant options (atomoxetine, bupropion, clonidine) for patients who can’t tolerate delays. Some patients may need to try multiple pharmacies or wait for restocks.

Can I treat ADHD in children via telehealth?

Yes, with some caveats. You need parental consent and ideally parental involvement in visits (especially for younger children). Rating scales from teachers and direct observation (even via video) help confirm diagnosis. Many states require the parent to be present during the telehealth visit for minors. Child psychiatry is in higher demand than ever — if you’re comfortable with pediatric populations, you’ll have a full schedule instantly.

Do insurance companies pay the same for telehealth ADHD visits as in-person?

Almost universally, yes. Telehealth parity is law or policy in 48+ states. Medicare, most commercial insurers, and even Medicaid now pay equal rates for video visits. You’ll bill the same CPT codes (99213, 99214, 90792) with a telehealth place-of-service code or modifier.

How many ADHD patients can I realistically see per week via telehealth?

Depends on your model. Follow-up medication management visits average 10-15 minutes. Initial evaluations take 45-60 minutes. A realistic schedule:

• 15-20 initial evaluations/week = ~15-20 hours
• Plus 40-60 follow-ups/week = ~10-15 hours
• Total: 25-35 clinical hours for a full-time equivalent caseload of 80-100+ active patients

Some providers do more (especially if focused only on med checks), others less (if they include therapy or have complex patients). Telehealth efficiency (no commute time for patients = fewer no-shows, easier to fill cancellations) means you can see more patients per hour than in traditional office settings.

Why Psychiatrists Choose Klarity Health for ADHD Telehealth

Look, there are dozens of telehealth platforms. Some are legitimately good. Others are just trying to scale fast and hoping providers don’t notice the chaos behind the curtain.

Here’s what matters when you’re evaluating where to hang your shingle:

Patient quality and volume. Can the platform actually deliver a steady stream of appropriate patients who show up, pay (or have good insurance), and stick around? Or are you going to spend half your time chasing no-shows and dealing with patients who thought this was a free consultation?

Compliance infrastructure. Is the platform set up to keep you compliant with state laws, DEA rules, PDMP requirements, and HIPAA? Or are you going to be the one scrambling when your state medical board sends an inquiry?

Reimbursement transparency. Do you know exactly what you’re getting paid per visit, and when? Or is there a convoluted tier system that changes every quarter?

Control over your schedule. Can you actually decide when you work and which patients you see? Or is the platform pushing you to take every available slot to hit their metrics?

Support for collaborative models. If you’re in a state where NPs need supervision, does the platform facilitate that (and compensate you for it)? Or do they expect you to figure out collaboration agreements on your own?

Klarity Health is built around these fundamentals. You get:

• Pre-qualified ADHD patients who’ve already been matched to your availability and insurance preferences
• Built-in compliance tools (PDMP integration, state-specific workflows, documentation templates that meet board standards)
• Pay-per-appointment model with transparent pricing (no hidden fees, no volume quotas, no bait-and-switch)
• Full schedule control — you decide how many patients, when, and what types of cases you want to take
• Support for team-based care in restricted states (collaborative agreements, supervision compensation, NP partnership models)
• Both insurance and cash-pay options so you can balance income and patient access

Most importantly: Klarity’s business model aligns with yours. We make money when you see patients and get paid. We don’t make money by burning through VC funding and hoping to flip the company before the unit economics collapse.

If you’re a psychiatrist who wants to treat ADHD patients without becoming a marketing expert, compliance attorney, and billing

Source:

• https://www.axios.com/2024/09/18/telehealth-services-controlled-substances-congress#:~:text=Why%20it%20matters%3A%20Pandemic,end%20of%20this%20year%20after
• https://www.axios.com/2024/11/18/covid-telehealth-prescribing-extended-adderall#:~:text=The%20Drug%20Enforcement%20Administration%20and,the%20third%20temporary%20extension%20of
• https://www.flsenate.gov/Laws/Statutes/2023/456.47#:~:text=,is%20prescribed%20for%20the%20following
• https://www.flsenate.gov/Laws/Statutes/2023/456.47#:~:text=1,disorder
• https://rxagent.co/blog/np-prescribing-authority#:~:text=OK%20%20,day%20%28ongoing%29%20%5B3
• https://rxagent.co/blog/np-prescribing-authority#:~:text=TN%20%20,NP%3A%20Independent%20%5B3
• https://rxagent.co/blog/np-prescribing-authority#:~:text=match%20at%20L210%20NY%20,terminal%20illness%2C%20MD%20initiation
• https://rxagent.co/blog/np-prescribing-authority#:~:text=ID%20%20,3
• https://rxagent.co/blog/np-prescribing-authority#:~:text=FL%20%20,NP%3A%20Independent%20%5B3
• https://www.leg.state.fl.us/STATUTeS/index.cfm?Appmode=DisplayStatute&Search_String=&URL=0400-0499%2F0464%2FSections%2F0464.012.html#:~:text=also%20limit%20the%20prescribing%20of,shall%20adopt%20by%20rule%20the